Lineage Cell Therapeutics, Inc. Announces Resignation of Chase C. Leavitt as General Counsel and Corporate Secretary, Effective April 7, 2021
March 26, 2021 at 05:23 pm EDT
On March 23, 2021, Chase C. Leavitt notified Lineage Cell Therapeutics, Inc. that he would be resigning as General Counsel and Corporate Secretary effective April 7, 2021 to accept a leadership position at another company. Mr. Leavitt's resignation was not the result of any disagreement with Lineage or its Board of Directors or any matter relating to Lineage's operations, policies, or practices.